ArticleBMJ global health2019
The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists.
Article in BMJ global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- A framework for enhancing pharmaceutical integrity and patient safety: novel mobile health solution integrating smart packaging and computer vision.Scientific reports · 2026Article
- Estimated prevalence of unregistered and falsified medicinal products in Malaysia: a nationwide cross-sectional study conducted from March to November 2023.Journal of pharmaceutical policy and practice · 2025Article
- The challenges associated with the prevention of smuggling and counterfeiting health goods in Iran.BMC public health · 2024Article
- Exploring pharmacists' perspectives about substandard and falsified medical products through interviews.Exploratory research in clinical and social pharmacy · 2024Article
- Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa.BMJ global health · 2023Article
- Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs.Annals of medicine and surgery (2012) · 2023Article
- Small-scale dissolution test screening tool to select potentially substandard and falsified (SF) medicines requiring full pharmacopoeial analysis.Scientific reports · 2021Article
- Negative Consequences of the Widespread and Inappropriate Easy Access to Purchasing Prescription Medications on the Internet.American health & drug benefits · 2021Review
- The Need for Ongoing Antimicrobial Stewardship during the COVID-19 Pandemic and Actionable Recommendations.Antibiotics (Basel, Switzerland) · 2020Article
- A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives.The journal of medicine accessReview
- Evaluation of pharmacists' awareness of illegal online pharmacies and perceived impact on safe access to medicines.Medicine access @ point of careArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.